Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
7.01
-0.04 (-0.57%)
Oct 10, 2025, 12:52 PM EDT - Market open
Cullinan Therapeutics Market Cap
Cullinan Therapeutics has a market cap or net worth of $414.11 million as of October 10, 2025. Its market cap has decreased by -59.53% in one year.
Market Cap
414.11M
Enterprise Value
152.51M
1-Year Change
-59.53%
Ranking
Category
Stock Price
$7.01
Market Cap Chart
Since the IPO on January 8, 2021, Cullinan Therapeutics's market cap has decreased from $829.45M to $414.11M, a decrease of -50.07%. That is a compound annual growth rate of -13.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2025 | 416.47M | -41.28% |
| Dec 31, 2024 | 709.21M | 62.69% |
| Dec 29, 2023 | 435.93M | -9.73% |
| Dec 30, 2022 | 482.90M | -28.36% |
| Dec 31, 2021 | 674.05M | -18.74% |
| Jan 8, 2021 | 829.45M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 767.88B |
| Johnson & Johnson | 460.19B |
| AbbVie | 407.53B |
| UnitedHealth Group | 333.01B |
| AstraZeneca | 266.28B |
| Novo Nordisk | 261.06B |
| Novartis AG | 256.06B |
| Abbott Laboratories | 232.02B |